Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11891450 Anti-CD47 agent-based treatment of CD20-positive cancer

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Date Filed
February 11, 2019
0
Date of Patent
February 6, 2024
0
Patent Application Number
16272350
0
Patent Citations
‌
US Patent 9352037 Compositions and methods to enhance the immune system
0
‌
US Patent 9790275 Compositions and methods to enhance the immune system
0
‌
US Patent 10081680 Anti-SIRP-alpha antibodies and bispecific macrophage enhancing antibodies
0
‌
US Patent 9920122 Compositions and methods to enhance the immune system
0
‌
US Patent 10287351 Compositions and methods to enhance the immune system
0
‌
US Patent 8728476 Compositions and methods to enhance the immune system
0
‌
US Patent 8758750 Synergistic anti-CD47 therapy for hematologic cancers
0
Patent Inventor Names
Mark Ping Chao
0
Jens-Peter Volkmer
0
Chris Hidemi Mizufune Takimoto
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11891450
0
Patent Primary Examiner
‌
Hong Sang
0
CPC Code
‌
C07K 2317/732
0
‌
A61K 39/39558
0
‌
A61K 2039/55
0
‌
A61K 2039/804
0
‌
A61K 2039/505
0
‌
A61K 2039/507
0
‌
A61K 2039/545
0
‌
A61P 35/00
0
‌
C07K 2317/24
0
‌
C07K 16/2887
0
•••

Find more entities like US Patent 11891450 Anti-CD47 agent-based treatment of CD20-positive cancer

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo